BBIO — BridgeBio Pharma Share News
0.000.00%
Last trade - 00:00- $13.12bn
- $15.77bn
- $502.08m
U.S. STOCKS ON THE MOVE-Verisk, Fiserv, Kraft Heinz
U.S. STOCKS ON THE MOVE- Verisk, Fiserv, Boeing
U.S. STOCKS ON THE MOVE-Fiserv, Centene, Hormel Foods
U.S. STOCKS ON THE MOVE-Copper miners, Kraft Heinz, Seagate
BridgeBio rises as its genetic disease drug meets goals in late-stage trial
BridgeBio's drug for genetic condition meets late-stage study goals (updated)
BridgeBio's drug for genetic condition meets main goals in late-stage study
Brief: BridgeBio Reports Positive Phase 3 Topline Results For Encaleret In Patients With Autosomal Dominant Hypocalcemia Type 1
U.S. STOCKS ON THE MOVE-PepGen, Turbo Energy, Qualcomm
BridgeBio rises as late-stage trial of muscle-wasting drug meets all goals
U.S. STOCKS ON THE MOVE-Alphabet, Keysight Technologies, Keurig Dr Pepper
BridgeBio jumps as late-stage trial of muscle-wasting drug meets all goals
BridgeBio's genetic muscle disorder drug meets all goals in late-stage trial (updated)
Brief: BridgeBio Says Fortify Phase 3 Study Meets All Primary & Secondary Interim Analysis Endpoints
BridgeBio's genetic muscle disorder drug meets all goals in late-stage trial
Brief: BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule
Brief: BridgeBio Pharma Says Acoramidis Reduces CVM Or CVH Risk By 49% Through Month 30
Brief: Bridgebio Pharma Says Intends To Initiate Registrational Clinical Study Of Encaleret In 2026
U.S. STOCKS ON THE MOVE- Shoe Carnival, Leidos Holdings, copper miners